Health Care
In a massive deal, Eli Lilly acquires Loxo Oncology
Eli Lilly and Company (LLY) on Monday announced that it would acquire a small biopharmaceutical startup that develops cancer treatment,…
Flexion Therapeutics plunges after reporting preliminary Q4 financial results
Flexion Therapeutics (Nasdaq: FLXN) reported its preliminary fourth quarter earnings results after the bell today. The biopharmaceutical company's Q4 revenue is expected…
Johnson & Johnson dips on revenue decline in India
Johnson & Johnson (JNJ) shares fell 1% on Thursday after the company reported a 3% sales dip in India in…
Bristol-Myers Squibb swallows Celgene for $74-bln; Celgene stock surges
Bristol-Myers Squibb (NYSE: BMY) acquired its peer Celgene (NASDAQ: CELG) in a $74-billion cash-and-stock deal. Under the agreement terms, Celgene…
Cambrex Corp. completes acquisition of Avista Pharma solutions
Life sciences company Cambrex Corp. (CBM) Wednesday completed its previously announced acquisition of Avista Pharma Solutions, a biotech firm engaged…
Aphria rejects Green Growth Brands’ $2.1-bln buyout offer
Aphria Inc. (NYSE: APHA and TSX: APHA) turned down the acquisition proposal by Xanthic Biopharma d.b.a. Green Growth Brands (CSE:…
Thailand legalizes medical use of cannabis, opens up a new region for pot stocks
After Uruguay and Canada, Thailand has now amended its drug law to legalize marijuana for medical purposes. However, unlike the…
Budweiser-parent mulls pot-based drinks, inks JV with Tilray
The world’s largest brewery and the parent company of Budweiser, AB InBev (BUD), has given potheads more reasons to cheer…
GSK teams up with Pfizer to announce major changes to business
GlaxoSmithKline plc (GSK) and Pfizer Inc. (PFE) have decided to combine their consumer health businesses in an all-equity transaction that…
Merck strengthens animal health division with $2.4-bln Antelliq buyout
Taking a cue from the growing demand for animal care products, healthcare service providers and pharma companies are enhancing their…